Sleepiness, circadian dysrhythmia, and fatigue in transportation system accidents.

J. Lauber,P. Kayten

DOI: https://doi.org/10.1093/SLEEP/11.6.503

IF: 6.313

1988-09-01

SLEEP

Abstract:

What problem does this paper attempt to address?

Thermodynamic Properties and Crystal Structures of the Adductive 2,6-Naphthalenedicarboxylic Acid Crystallization with N,N-Dimethyl Acetamide and N-Methyl Pyrrolidone

Bianhua Wu,Youwei Cheng,Xi Li

DOI: https://doi.org/10.1021/je2009973

2012-01-01

Abstract:The crystal structures and thermodynamic properties of NDA-DMAC and NDA-NMP adduct crystals, the solubilities of 2,6-naphthalenedicarboxylic acid (NDA) in N,N-dimethyl acetamide (DMAC) and N-methyl pyrrolidone (NMP) over a temperature range from (293.2 to 373.2) K were studied in this paper. The results show that: (1) The asymmetric units of NDA-DMAC and NDA-NMP adduct crystals both contain one half molecule of NDA and one molecule of the solvent which are linked mainly by hydrogen bonds. (2) The thermal stabilities of the two adducts are both poor, and the initial dissociation temperature of NDA-DMAC and NDA-NMP adducts are about 306.29 K and 322.75 K, respectively. (3) The solubilities of NDA in DMAC and NMP solvents at (293.2 to 373.2) K both increase with the rise of experimental temperature. Below the dissociation temperature, the equilibrium solid phase is the, adduct crystal with the adduct solvent. Otherwise, the equilibrium solid phase is the pure NDA solid with the adduct crystal dissociating. The solubility data are correlated by the Buchowski equation or the nonrandom two-liquid (NRTL) activity coefficient model.
Crystal Structures and Pore Stability of Coordination Polymers Constructed by Nicotinic Acid and Isonicotinic Acid with Co(II)

Hua Xiao-Hu,Li Wei-Hong,Xu Yi-Zhuang,Wu Jin-Guang

DOI: https://doi.org/10.3866/pku.whxb201206123

2012-01-01

Abstract:Nicotinic acid and isonicotinic acid were utilized to react with Co(NO3)(2) in N,N'-dimethylformamide (DMF) in solvothermal conditions respectively, and resulted in three new coordination polymers: [Co-2(mu(2)-H2O)(nicotinic acid)(4) center dot (DMF)] (1), [Co-2(isonicotinic acid)(4) center dot (DMF)] (2), and [Co(isonicotinic acid)(2) center dot (DMF)] (3). Single crystal X-ray diffraction (XRD) and elemental analysis were performed to obtain structural information on these compounds. Fourier transform infrared (FTIR) spectroscopy, thermogravimetric analysis (TGA), and N-2 isotherm analysis were utilized to investigate the pore stability of the three compounds. The above experiments reveal that compound 1 has a diamond-like topology, and the one-dimensional (1D) channels in compound 1 are stable after the removal of DMF molecules. Compounds 2 and 3 were synthesized at 100 and 160 degrees C by the coordination of isonicotinic acid with Co(II), respectively. The coordination modes of isonicotinic acid to Co(II) are completely different in the two compounds, which lead to two different crystal structures. The 1D channels in compounds 2 and 3 were not stable after the removal of DMF molecules.
Pharmaceutical cocrystal consisting of ascorbic acid with p-aminobenzoic acid and paracetamol

Fatima Miles,Fayrouz Djellouli,Nourelhouda Bensiradj,Abdallah Dahmani

DOI: https://doi.org/10.1515/psr-2021-0199

2022-05-23

Physical Sciences Reviews

Abstract:As small molecule drugs become harder to develop and less cost effective for patient use, efficient strategies for their property improvement become increasingly important for global health initiatives. As a new crystal engineering strategy, cocrystals have opened a new way to modify the physicochemical properties of pharmaceutical solids. Improvements in the physical properties of Active Pharmaceutical Ingredients (APIs) without changes in the covalent chemistry have been possible through the application of binary component solids. In this work, a pharmaceutical cocrystal of ascorbic acid (A) + para-aminobenzoic acid (B) and ascorbic acid (A) + paracetamol (P) cocrystal are synthesized and characterized by PXRD, DSC, and FT-IR. FT-IR indicates the kind of interactions occurring between API and coformer. The DSC thermogram for (A–B) cocrystal showed a single endothermic peak attributed to the melting temperature at 155 °C. The thermal behavior of the cocrystal was distinct with different melting temperatures from that seen with either of the individual components; this suggests the formation of a new phase. As molecular modeling is presented as a support to the experiment, a computational study using density functional theory (DFT) at the level of the WB97XD functional and 6-311 + G (d, p) basis set was carried out using the Gaussian 09 program. This theoretical study made it possible to calculate the energetic properties, the intramolecular hydrogen bonds as well as the thermodynamic properties for the two cocrystals.
Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide

Muhammad Inam,Jiajia Wu,Jie Shen,Chi Uyen Phan,Guping Tang,Xiurong Hu

DOI: https://doi.org/10.3390/cryst8090336

IF: 2.7

2018-01-01

Crystals

Abstract:Two new co-crystals, Ticagrelor with Nicotinamide, have been prepared with improved solubility. Because Ticalegor has a poor solubility and dissolution rate, a novel co-crystallization method with structurally homogenous crystalline material, an active pharmaceutical ingredient (API), and co-former indefinite stoichiometric amount has been made to improve Ticagrelor’s solubility. The co-crystal of Ticagrelor (TICA) with Nicotinamide (NCA) was prepared in ratio (1:1) and confirmed by FTIR, DSC, and XRD characterization. Furthermore, the single crystal structure of TICA-NCA hydrate was analyzed. The solubility of co-crystals was investigated in pH 2 acidic medium, which was a significant improvement as compared to the solubility of a free drug. The in vitro dissolution rate of co-crystal was larger than that of the commercial product.
Crystal Structure,Interaction with DNA and BSA and Antiproliferative Activities of Cobalt(Ⅱ) Complex with Demethylcantharate and 2-Aminopyridine

ZHANG Fan,LIN Qiu-Yue,ZHENG Bo-Wen,HU Yi-Dan,ZHENG Xiao-Shi

2012-01-01

Chinese journal of inorganic chemistry

Abstract:A cobalt(II) complex (Hapy)(2)[Co(DCA)(2)]center dot 6H(2)O (DCA=demethylcantharate, 7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylate, C8H8O5; Hapy=2-aminopyriclinum, C5H7N2) was synthesized and characterized by elemental analysis, molar conductance, infrared spectra, thermogravimetric analysis and X-ray diffraction. The complex crystallized in the triclinic crystal system, P (1) over bar space group, with a=0.662 23(7) nm, b=1.016 41(11) nm, c =1.194 60(12) nm, V=0.792 49(14) nm(3), Z=1, D-c=1.520 g.cm(-3), M-r=725.57, lambda(Mo K alpha)=0.071 073 nm, F(000)=381, R=0.028 3 and wR=0.082 1 (1>2 sigma (I)). The coordination number of metal ion was six and DCA ions were tridentate ligand. DNA binding property of the complex was investigated by fluorescence spectra and viscosity measurements. Results indicated the complex could bind to DNA via partial intercalation mode. The value of quenching constant K-sq, was 0.18. The interaction of the complex with bovine serum albumin (BSA) was also studied by fluorescence spectra. The results suggested that the complex could quench the fluorescence of BSA with the binding constant K-a of 3.88x10(6) L . mol(-1). The antiproliferative activity test revealed that complex showed stronger inhibition ratios against human hepatoma cells (SMMC-7721) lines and human gastric cancer cells (MGC80-3) lines than Na-2 (DCA) in vitro. CCDC: 823705.
Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations

Mei Wan,Jiyuan Fang,Jiadan Xue,Jianjun Liu,Jianyuan Qin,Zhi Hong,Jiusheng Li,Yong Du

DOI: https://doi.org/10.3390/ijms23158550

2022-08-01

Abstract:Pharmaceutical cocrystals can offer another advanced strategy for drug preparation and development and can facilitate improvements to the physicochemical properties of active pharmaceutical ingredients (APIs) without altering their chemical structures and corresponding pharmacological activities. Therefore, cocrystals show a great deal of potential in the development and research of drugs. In this work, pharmaceutical cocrystals of ethenzamide (ETZ) with 2,6-dihydroxybenzoic acid (26DHBA), 2,4-dihydroxybenzoic acid (24DHBA) and gallic acid (GA) were synthesized by the solvent evaporation method. In order to gain a deeper understanding of the structural changes after ETZ cocrystallization, terahertz time domain spectroscopy (THz-TDS) and Raman spectroscopy were used to characterize the single starting samples, corresponding physical mixtures and the cocrystals. In addition, the possible molecular structures of ETZ-GA, ETZ-26DHBA and ETZ-24DHBA cocrystals were optimized by density functional theory (DFT). The results of THz and Raman spectra with the DFT simulations for the three cocrystals revealed that the ETZ-GA cocrystal formed an O-H∙∙∙O hydrogen bond between the -OH of GA and oxygen of the amide group of the ETZ molecule, and it was also found that ETZ formed a dimer through a supramolecular amide-amide homosynthon; meanwhile, the ETZ-26DHBA cocrystal was formed by a powerful supramolecular acid-amide heterosynthon, and the ETZ-24DHBA cocrystal formed the O-H∙∙∙O hydrogen bond between the 4-hydroxy group of 24DHBA and oxygen of the amide group of the ETZ molecule. It could be seen that in the molecular structure analysis of the three cocrystals, the position and number of hydroxyl groups in the coformers play an essential role in guiding the formation of specific supramolecular synthons.
Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

Aishwarya Savale,Rajendra Mogal,Swati Talele,Sumit Deore,Laxmikant Borse

DOI: https://doi.org/10.13005/bbra/3168

2023-12-31

Biosciences Biotechnology Research Asia

Abstract:ABSTRACT: Poor physicochemical properties like solubility, dissolution profile, stability, etc. of drugs remain as an obstacle to formulation development. In the last two decades, pharmaceutical cocrystal gaining lots of interest from researchers as these physicochemical, mechanical, and pharmacokinetic properties can be altered without compromising the therapeutic effect. The multi-component systems wherein one component is essentially the Active Pharmaceutical Ingredient and another may be either one more drug or coformer are termed as pharmaceutical cocrystal. Cocrystal is a novel, promising, and emerging approach to encountering such problems and improving the performance of pharmaceuticals. The present article describes the types, rationale of design, synthesis methods, and characterization of pharmaceutical cocrystals. In addition to this, challenges before and after synthesizing cocrystal along with currently approved formulations based on the pharmaceutical cocrystal approach and cocrystals under clinical investigation are highlighted.
Insight into the Formation of Cocrystal and Salt of Tenoxicam from the Isomer and Conformation

Yifei Xie,Penghui Yuan,Tianyu Heng,Lida Du,Qi An,Baoxi Zhang,Li Zhang,Dezhi Yang,Guanhua Du,Yang Lu

DOI: https://doi.org/10.3390/pharmaceutics14091968

IF: 6.525

2022-09-20

Pharmaceutics

Abstract:Tenoxicam (TNX) is a new non-steroidal anti-inflammatory drug that shows a superior anti-inflammatory effect and has the advantages of a long half-life period, a fast onset of action, a small dose, complete metabolism, and good tolerance. Some compounds often have tautomerism, and different tautomers exist in different crystalline forms. TNX is such a compound and has three tautomers. TNX always exists as the zwitterionic form in cocrystals. When the salt is formed, TNX exists in the enol form, which exhibits two conformations depending on whether a proton is gained or lost. Currently, the crystal structure of the keto form is not in the Cambridge Structural Database (CSD). Based on the analysis of existing crystal structures, we derived a simple rule for what form of TNX exists according to the pKa value of the cocrystal coformer (CCF) and carried out validation tests using three CCFs with different pKa values, including p-aminosalicylic acid (PAS), 3,5-dinitrobenzoic acid (DNB), and 2,6-dihydroxybenzoic acid (DHB). The molecular surface electrostatic potential (MEPS) was combined with the pKa rule to predict the interaction sites. Finally, two new cocrystals (TNX-PAS and TNX-DNB) and one salt (TNX-DHB) of TNX were obtained as expected. The differences between the cocrystals and salt were distinguished by X-ray diffraction, vibration spectra, thermal analysis, and dissolution measurements. To further understand the intermolecular interactions in these cocrystals and salt, the lattice energy and energy decomposition analysis (EDA) were used to explain them from the perspective of energy. The results suggest that the melting point of the CCF determines that of the cocrystal or salt, the solubility of the CCF itself plays an important role, and the improvement of the solubility after salt formation is not necessarily better than that of API or its cocrystals.

pharmacology & pharmacy
Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential

Julius F Remenar,Matthew L Peterson,Peter W Stephens,Zhong Zhang,Yuri Zimenkov,Magali B Hickey

DOI: https://doi.org/10.1021/mp0700108

Abstract:The cocrystal of celecoxib and nicotinamide (Cel:Nic) was crystallized from chloroform in a 1:1 ratio, and the structure has been solved from powder X-ray diffraction data. The dissolution and solubility of Cel:Nic are medium dependent and can be attributed to differences in conversion of Cel:Nic to celecoxib polymorphs I and III (Cel-I and Cel-III). The presence of low concentrations of surfactants facilitates the rapid conversion of neat Cel:Nic to large aggregates of Cel-III that dissolve more slowly than commercial Cel-III into 1% SDS solution. In contrast, combinations of Cel:Nic with both 1-10% solid SDS and PVP wet rapidly and convert to a mixture of amorphous celecoxib and a micron-sized crystalline celecoxib form IV (Cel-IV), which has recently been shown to be up to 4-fold more bioavailable than marketed Cel-III. More than 90% of the suspended material dissolves within 2 min at 37 degrees C when transferred to 1% SDS solution. This example highlights the importance of exploring the form conversion of cocrystals in aqueous media prior to pharmacokinetic studies, and illustrates the potential of simple formulations to overcome the limitations caused by rapid dissociation of cocrystals and recrystallization of poorly soluble forms in aqueous media.
Synthesis, Performance, and Thermal Behavior of Two Insensitive 3,4-Dinitropyrazole-Based Energetic Cocrystals

Qamar-un-Nisa Tariq,Yu-fan Bi,Saira Manzoor,Maher-un-Nisa Tariq,Wen-Li Cao,Wen-Shuai Dong,Jian-Guo Zhang

DOI: https://doi.org/10.1021/acs.cgd.2c00809

IF: 4.01

2022-12-12

Crystal Growth & Design

Abstract:Due to the acidity and the limited applications of 3,4-dinitropyrazole (DNP), two types of nitrogen-rich energetic cocrystals (DD1 and DD2) based on DNP and 3,4-diaminofurazan (DAF) were synthesized. The magnificently grown cocrystals were thoroughly examined by Fourier transform infrared spectroscopy, powder X-ray diffraction, single-crystal X-ray diffraction, elemental analysis, and nuclear magnetic resonance. A differential scanning calorimetry analysis revealed that both cocrystals have different endothermic peaks and remarkably similar exothermic peaks. Moreover, thermogravimetric analysis demonstrates that the thermal decomposition of DD1 and DD2 seems to be three mass loss stages. Hirshfeld surface analysis suggests that O···H (hydrogen bonding) close contacts contribute the most to the stabilization of DD1 and DD2. Subsequently, the pH values of DD1 and DD2 indicate that cocrystals reduce the acidity of DNP; additionally, the inclusion of hydrogen peroxide can improve the oxygen balance of the cocrystal to a certain degree. The obtained cocrystals have high nitrogen contents and acceptable sensitivities to external stimuli (friction and impact) that prove them as promising candidates for expanding the applications of DNP in the field of energetic materials after overcoming an acidity problem.

chemistry, multidisciplinary,materials science,crystallography
X-Ray Diffraction and Theoretical Calculation-Supported Formation of Polymorphic Cocrystals Discovered Through Thermal Methods: A Case Study

Zhengzheng Zhou,Mónica Calatayud,Julia Contreras-García,Liang Li,Henry H Y Tong,Ying Zheng

DOI: https://doi.org/10.1016/j.xphs.2019.05.019

Abstract:Polymorphism commonly exists in the preparation of cocrystals and has attracted widespread attention from both the pharmaceutical industry and academia. However, few studies have examined how to discover polymorphic cocrystals and their potential formation mechanism. In this study, we report the novel discovery of salicylic acid: 3-nitrobenzamide (SA-3NBZ) polymorphic cocrystals by thermal methods. The formation mechanism is elucidated based on theoretical calculations. SA-3NBZ polymorphic cocrystals with molar ratio of 1:1 and 2:2 were discovered using the combination of differential scanning calorimetry and hot stage microscopy. Single-crystal X-ray diffraction analysis confirmed this discovery. Density functional theory calculations corrected with dispersion were conducted to illustrate the energetic stabilization of SA polymorphic cocrystals. Compared with the starting materials, formation of the cocrystals at 1:1 and 2:2 present a weak stabilization with overall energy reduction of -0.01 and -0.05 eV/molecule, respectively. The calculated noncovalent interactions index further suggests that intralayer hydrogen bonds and van der Waals forces contribute to these weak interactions. The density functional theory calculations are in good agreement with the X-ray diffraction data. Hence, thermal analysis is a simple and reliable method to discover polymorphic cocrystals.
A DFT study on the structure activity relationship of the natural xanthotoxin-based pharmaceutical cocrystals

Shaohang Yuan,Zhiguang Yang,Changjiao Shang,Danyang Yang,Yuxuan Wang,Haifei Qi,Chaofan Sun,Lingling Wang,Xiuhua Zhao

DOI: https://doi.org/10.1007/s00894-022-05152-5

IF: 2.172

2022-05-18

Journal of Molecular Modeling

Abstract:In this work, the pharmaceutical cocrystals xanthotoxin-para-aminobenzoic acid (XT-PABA) and xanthotoxin-oxalic acid (XT-OA) were systematically investigated in the gas and water phases by using the quantum chemical approach. The weak intermolecular interactions have been estimated and the O1...H4 (O1...H5) intermolecular hydrogen bond (IHB) with moderate intensity and partial covalent natures was confirmed based on the computed structural parameters, topology analysis, and reduced density gradient (RDG) isosurfaces. The electrophilic and nucleophilic reactivities of different positions associated with intermolecular interactions in XT, PABA, and OA were predicted by plotting the molecular electrostatic potential (MESP) diagrams. The calculated natural bond orbital (NBO) population analysis has quantitatively unveiled the intrinsic reason for the variations in weak intermolecular interactions within XT-PABA and XT-OA cocrystals, from the gas phase to the water phase. Besides, the frontier molecular orbitals (FMOs), Fukui function, and various global reactivity descriptors were computed to measure the chemical reactivity of all the investigated molecular systems. The XT-PABA and XT-OA cocrystals explored in this work could be regarded as valuable exemplar systems to design and synthesize the high-efficiency pharmaceutical cocrystals in the experiment.

chemistry, multidisciplinary,biochemistry & molecular biology,biophysics,computer science, interdisciplinary applications
Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Dabing Chen,Wenjun Huang,Qinfang Zhang,Zenghui Zhang,Yiwang Guo,Gerrit Vreeman,Changquan Calvin Sun,Michael Hawley,Bing-Shiou Yang,Xiaorong He

DOI: https://doi.org/10.1021/acs.cgd.1c00950

IF: 4.01

2022-08-16

Crystal Growth & Design

Abstract:Cocrystal engineering for bioavailability enhancement is still a serendipitous process, which requires systematic solution crystallization, in vivo predictive dissolution, and biopharmaceutical simulation. The purpose of this study is to improve bioavailability through cocrystal engineering, with a focus on understanding the mechanism of supersaturation maintenance during dissolution. BI 639667 is a poorly soluble and fast precipitating compound. The ability of its cocrystal with salicylic acid (SA) to maintain supersaturation was assessed using a modified two-step dissolution method, and its bioavailability was determined in rats. Biopharmaceutical simulation and dissolution modeling were performed to predict the in vivo performance in humans. Conductor-like screening model for realistic solvents and molecular dynamics (MD) simulation were used to study the interactions between the active pharmaceutical ingredient (API) and coformers in vacuum and aqueous media, respectively. A high melting cocrystal with SA, crystallized in dichloromethane, showed moderate solubility enhancement with prolonged supersaturation during dissolution, which was able to enhance bioavailability with reduced C max, compared to amorphous dispersion. The radial distribution function (RDF) between the API and selected coformers was calculated using MD simulation to determine the mean distance between the API and coformer molecules in aqueous media. The result suggests that SA could better compete against water for interactions with the API and could penetrate the API molecular clusters to inhibit nucleation. Thus, the RDF by MD simulation may be used to determine the disruptive effect of water on the interaction between the API and coformer and improve cocrystal engineering for bioavailability enhancement.

chemistry, multidisciplinary,materials science,crystallography
Supramolecular Synthons and Hydrates in Stabilization of Multicomponent Crystals of Nicotinamide and Isonicotinamide with N-Containing Aromatic Dicarboxylic Acids

Babulal Das,Jubaraj B. Baruah

DOI: https://doi.org/10.1021/cg201096c

2011-10-26

Abstract:Multicomponent crystals (either cocrystal or salt) of nicotinamide (nicotinic acid amide) and isonicotinamide with various nitrogen heterocycle-containing aromatic dicarboxylic acids, namely, 3,5-pyrazole dicarboxylic acid (pzdca), dipicolinic acid (dpa), and quinolinic acid (qna), have been synthesized and characterized by single-crystal diffraction and thermal studies. The nicotinamide (nic) and isonicotinamide (isonic) cocrystals with 3,5-pyrazole dicarboxylic acid (1 and 2, respectively) possess four different heteromeric supramolecular synthons in each cocrystal, which is rare. The nicotinamide dipicolinic acid cocrystal, 3, showed formation of water-bridged assembly, whereas isonicotinamide-dipicolinic acid cocrystal, 4, led to a six-component assembly through the isolated solvent water molecules occupying the interstitial positions. The salt formed from quinolinic acid with nicotinamide 5 has a hydrogen-bonded 1D water chain in its crystal lattice, whereas quinolinic acid with isonicotinamide resulted in formation of 6 with 2D sheets of multiple heterosynthons. Thermal studies show evaporation of various water molecules with a trend that has relevance to their hydrogen-bonding environment in the multicomponent crystal.

chemistry, multidisciplinary,materials science,crystallography
Salt Cocrystal of Diclofenac Sodium-L-Proline: Structural, Pseudopolymorphism, and Pharmaceutics Performance Study

Ilma Nugrahani,Rizka A. Kumalasari,Winni N. Auli,Ayano Horikawa,Hidehiro Uekusa

DOI: https://doi.org/10.3390/pharmaceutics12070690

IF: 6.525

2020-07-21

Pharmaceutics

Abstract:Previously, we have reported on a zwitterionic cocrystal of diclofenac acid and L-proline. However, the solubility of this multicomponent crystal was still lower than that of diclofenac sodium salt. Therefore, this study aimed to observe whether a multicomponent crystal could be produced from diclofenac sodium hydrate with the same coformer, L-proline, which was expected to improve the pharmaceutics performance. Methods involved screening, solid phase characterization, structure determination, stability, and in vitro pharmaceutical performance tests. First, a phase diagram screen was carried out to identify the molar ratio of the multicomponent crystal formation. Next, the single crystals were prepared by slow evaporation under two conditions, which yielded two forms: one was a rod-shape and the second was a flat-square form. The characterization by infrared spectroscopy, thermal analysis, and diffractometry confirmed the formation of the new phases. Finally, structural determination using single crystal X-ray diffraction analysis solved the new salt cocrystals as a stable diclofenac–sodium–proline–water (1:1:1:4) named NDPT (natrium diclofenac proline tetrahydrate), and unstable diclofenac–sodium–proline–water (1:1:1:1), named NDPM (natrium diclofenac proline monohydrate). The solubility and dissolution rate of these multicomponent crystals were superior to those of diclofenac sodium alone. The experimental results that this salt cocrystal is suitable for further development.

pharmacology & pharmacy
Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form

Fei Ding,Wei Cao,Runze Wang,Ningning Wang,Anran Li,Yuanfeng Wei,Shuai Qian,Jianjun Zhang,Yuan Gao,Zunting Pang

DOI: https://doi.org/10.1016/j.xphs.2022.08.031

Abstract:Recently, coamorphization and cocrystal technologies are of particular interest in the pharmaceutical industry due to their ability to improve the solubility/dissolution and bioavailability of poorly water-soluble drugs, while the coamorphous system often tends to convert into the stable crystalline form usually crystalline physical mixture of each component during formulation preparation or storage. In this paper, BCS II drug baicalein (BAI) along with nicotinamide (NIC) were prepared into a single homogeneous coamorphous system with a single transition temperature at 42.5 °C. Interestingly, instead of the physical mixture of crystalline BAI and NIC, coamorphous BAI-NIC would transform to its cocrystal form under stress of temperature and humidity. The transformation rate under isothermal condition was temperature-dependent, since the crystallinity of the cocrystal enhanced as the temperature increased. Further mechanic studies showed the activation energy for the transformation under non-isothermal condition was calculated to be 184.52 kJ/mol. Additionally, water vapor sorption tests with further solid characterizations indicated the transformation was faster under higher humidity condition due to the faster nucleation process of cocrystal BAI-NIC. This research not only discovered the mechanism of transformation from coamorphous BAI-NIC to cocrystal form, but also provided an unusual method for cocrystal preparation from its coamorphous form.
Preparation and Structure Analysis of Non-covalent Interactions Mediated 2D-3D Supramolecular Adducts from 6-methylnicotinamide and Carboxylic Acids

Yujiu Wu,Jingxuan Zhou,Shouwen Jin,Bin Liu,Chengzhe Shi,Daqi Wang,Jingxian Zhou,Hui Liu

DOI: https://doi.org/10.1016/j.molstruc.2022.133135

IF: 3.841

2022-04-01

Journal of Molecular Structure

Abstract:6-methylnicotinamide was utilized to create co-crystal/salts for the first time. By introducing it into the co-crystallization system based on different carboxylic acids of mono- to dicarboxylic acids, a total of six novel adducts including one cocrystal (6) and five salts (1–5) were engendered. They have been featured by SCXRD, IR and EA, their m.p. were also surveyed. Their structural and supramolecular portions are fully examined. The outcome unveils that in all salts the pyridine N is the only protonated location. The crystal piling is stitched by the strong NH···O, OH···N and OH···O H-bonds. The CONH2 dimerized in 5 and 6 with the help of twain NH···O H-bonds. Deep view of the crystal packing opened that a distinct set of subsidiary CH2C, CHN, CH···O/CH3···O, CH-S, OC, OO, O···π, π···C, S-π, CH···π/CH2-π/CH3-π and π···π connections conduce to the steadiness and growth of the overall 2D-3D structures. For the exquisite equilibrium of the various non-covalent links there embedded the homo/hetero supramolecular synthons or both, the universal R22(7)/R22(8) graphs have been the top encountered ones. The present findings lay the seat for burgeoning new solids of 6-methylnicotinamide, and furnish some new views into its co-crystals/salts with the carboxylic acids.

chemistry, physical
A Drug–Drug Cocrystal of Dihydromyricetin and Pentoxifylline

Lei Liu,Yanguang Li,Mei Zhang,Yanjie Zhang,Benyong Lou

DOI: https://doi.org/10.1016/j.xphs.2021.06.021

IF: 3.8

2022-01-01

Journal of Pharmaceutical Sciences

Abstract:Drug-drug cocrystals, which can regulate physicochemical properties of individual drugs and might produce synergistic therapeutic effects, have drawn growing interest in the pharmaceutical industry. In this study, a novel drug-drug (1:1) cocrystal hydrate of slightly water-soluble dihydromyricetin (DMY) and highly water-soluble pentoxifylline (PTX), DMY-PTX•H2O (1), was prepared by a slurry method. The single-crystal X-ray diffraction results reveal that the cocrystal is formed through hydrogen-bonding interactions between hydroxyl groups of DMY and four acceptors of PTX. The dynamic vapour sorption results indicate that the cocrystal displays reduced hydrophilicity compared with DMY. It is found that cocrystal formation narrows the solubility difference between two parent drugs. The equilibrium solubility of PTX decreases greatly, while that of DMY increases slightly. As a result, DMY and PTX are synchronously and sustainedly released from the cocrystal. Further, a synergistic anti-cancer effect of the cocrystal DMY-PTX•H2O (1) on HepG2 cells in vitro at a drug concentration of 100 μM was discovered. This study brings evidence of cocrystallization as a successful approach for synchronous sustained-release of two drugs with substantially different aqueous solubility.

pharmacology & pharmacy,chemistry, medicinal, multidisciplinary
Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage

Ioana Sovago,Wenbo Wang,Danwen Qiu,Dhara Raijada,Jukka Rantanen,Holger Grohganz,Thomas Rades,Andrew Bond,Korbinian Löbmann

DOI: https://doi.org/10.3390/molecules21040509

IF: 4.6

2016-04-19

Molecules

Abstract:Co-crystals and co-amorphous systems are two strategies to improve the physical properties of an active pharmaceutical ingredient and, thus, have recently gained considerable interest both in academia and the pharmaceutical industry. In this study, the behavior of the recently identified sodium naproxen-lactose-tetrahydrate co-crystal and the co-amorphous mixture of sodium, naproxen, and lactose was investigated. The structure of the co-crystal is described using single-crystal X-ray diffraction. The structural analysis revealed a monoclinic lattice, space group P21, with the asymmetric unit containing one molecule of lactose, one of naproxen, sodium, and four water molecules. Upon heating, it was observed that the co-crystal transforms into a co-amorphous system due to the loss of its crystalline bound water. Dehydration and co-amorphization were studied using synchrotron X-ray radiation and thermogravimetric analysis (TGA). Subsequently, different processing techniques (ball milling, spray drying, and dehydration) were used to prepare the co-amorphous mixture of sodium, naproxen, and lactose. X-ray powder diffraction (XRPD) revealed the amorphous nature of the mixtures after preparation. Differential scanning calorimetry (DSC) analysis showed that the blends were single-phase co-amorphous systems as indicated by a single glass transition temperature. The samples were subsequently tested for physical stability under dry (silica gel at 25 and 40 °C) and humid conditions (25 °C/75% RH). The co-amorphous samples stored at 25 °C/75% RH quickly recrystallized into the co-crystalline state. On the other hand, the samples stored under dry conditions remained physically stable after five months of storage, except the ball milled sample stored at 40 °C which showed signs of recrystallization. Under these dry conditions, however, the ball-milled co-amorphous blend crystallized into the individual crystalline components.

chemistry, multidisciplinary,biochemistry & molecular biology
Microelectron Diffraction Reveals Contamination of Polymorphs by Structure Analysis of Microscale Crystals in a Novel Pharmaceutical Cocrystal

Tetsuya Miyano,Yuya Hirakawa,Akihito Yamano,Hiroshi Ueda

DOI: https://doi.org/10.1021/acs.cgd.3c00468

IF: 4.01

2023-10-04

Crystal Growth & Design

Abstract:A P2X7 receptor antagonist (basic nature) with possible amino/imino tautomeric forms was used as an active pharmaceutical ingredient (API). After the amorphous form was confirmed by powder X-ray diffraction (PXRD), crystallization was performed using various organic solvents. Crystal forms I–VI were obtained, and thermal and NMR analyses suggested the presence of solvate forms. A multicomponent crystal of form VII, containing succinic acid, was successfully obtained. Form VII was predicted to be a cocrystal based on the ΔpK a between the API and succinic acid. The stoichiometry of API and succinic acid was 2:1, as determined by TG–DTA and nuclear magnetic resonance analyses. Single-crystal XRD analysis was performed to determine the crystal tautomerism of form VII. However, no diffraction peaks were observed, owing to the streaky morphology. Hence, microelectron diffraction (MED) analysis was performed, and electron diffraction patterns were obtained, revealing unexpected polymorphic forms VII-A and VII–B. Similar dimer formation between the triazine and hydroxyl groups of the APIs was confirmed for both polymorphs, suggesting a tautomeric imino form. Intermolecular interactions were observed between the API imidazole group and the carboxylic acid group of succinic acid; however, these modes differed between forms VII-A and VII-B. Taken together, the MED analysis accurately revealed the crystal structures, particularly for isomeric and/or multicomponent crystals with poor growth.

chemistry, multidisciplinary,materials science,crystallography

Sleepiness, circadian dysrhythmia, and fatigue in transportation system accidents.

Thermodynamic Properties and Crystal Structures of the Adductive 2,6-Naphthalenedicarboxylic Acid Crystallization with N,N-Dimethyl Acetamide and N-Methyl Pyrrolidone

Crystal Structures and Pore Stability of Coordination Polymers Constructed by Nicotinic Acid and Isonicotinic Acid with Co(II)

Pharmaceutical cocrystal consisting of ascorbic acid with p-aminobenzoic acid and paracetamol

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide

Crystal Structure,Interaction with DNA and BSA and Antiproliferative Activities of Cobalt(Ⅱ) Complex with Demethylcantharate and 2-Aminopyridine

Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

Insight into the Formation of Cocrystal and Salt of Tenoxicam from the Isomer and Conformation

Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential

Synthesis, Performance, and Thermal Behavior of Two Insensitive 3,4-Dinitropyrazole-Based Energetic Cocrystals

X-Ray Diffraction and Theoretical Calculation-Supported Formation of Polymorphic Cocrystals Discovered Through Thermal Methods: A Case Study

A DFT study on the structure activity relationship of the natural xanthotoxin-based pharmaceutical cocrystals

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

Supramolecular Synthons and Hydrates in Stabilization of Multicomponent Crystals of Nicotinamide and Isonicotinamide with N-Containing Aromatic Dicarboxylic Acids

Salt Cocrystal of Diclofenac Sodium-L-Proline: Structural, Pseudopolymorphism, and Pharmaceutics Performance Study

Mechanistic Study on Transformation of Coamorphous Baicalein-Nicotinamide to Its Cocrystal Form

Preparation and Structure Analysis of Non-covalent Interactions Mediated 2D-3D Supramolecular Adducts from 6-methylnicotinamide and Carboxylic Acids

A Drug–Drug Cocrystal of Dihydromyricetin and Pentoxifylline

Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage

Microelectron Diffraction Reveals Contamination of Polymorphs by Structure Analysis of Microscale Crystals in a Novel Pharmaceutical Cocrystal